Skip to main content
TipRanks
Go Ultimate75% OFF

Great Novel Therapeutics Biotech & Medicals Corp. (7427) Cash flow

Great Novel Therapeutics Biotech & Medicals Corp. Cash Flow

TW:7427's free cash flow for Q2 2026 was NT$0.00. For the 2026 fiscal year, TW:7427's free cash flow was increased by NT$50.03M and operating cash flow was NT$-50.03M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -87.85MNT$ -76.85MNT$ -54.99MNT$ -65.81MNT$ -33.92M
NT$ 9.37MNT$ -133.49MNT$ -182.78MNT$ -89.21MNT$ -90.32M
NT$ -46.74MNT$ 185.84MNT$ 306.24MNT$ 203.31MNT$ 120.00M
NT$ 29.84MNT$ 155.06MNT$ 179.55MNT$ 111.08MNT$ 62.79M
NT$ -88.13MNT$ -80.31MNT$ -57.92MNT$ -78.39MNT$ -61.92M

Currency in TWD

Great Novel Therapeutics Biotech & Medicals Corp. Cash Flow

-300M-200M-100M0100M200M300M400M201720182019202020212022202320242025OperatingInvestingFinancing